Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 1.99 is 40% below its 5-year average of 3.31, around the middle of its 5-year range (0.00–6.00).
As of the fiscal period ended Tuesday, June 30, 2026. 64.33% above its 12-month average of 1.21.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.99.
CURRENT RATIO
1.99
CURRENT RATIO AVG TTM
1.21
CURRENT RATIO AVG 3Y
2.21
CURRENT RATIO AVG 5Y
3.31
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+64.33%
CURRENT VS 3Y AVG
-9.79%
CURRENT VS 5Y AVG
-39.87%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.76
median of 873 covered companies
CURRENT VS SECTOR MEDIAN
-47.09%
vs the sector median at left
Market Cap
$4.40M
Current Ratio
1.57
TTM Avg
3.49
3Y Avg
6.45
5Y Avg
7.07
Market Cap
$4.21M
Current Ratio
0.87
TTM Avg
1.88
3Y Avg
4.97
5Y Avg
8.67
Market Cap
$4.53M
Current Ratio
40.30
TTM Avg
26.48
3Y Avg
43.98
5Y Avg
50.08
Market Cap
$4.55M
Current Ratio
2.81
TTM Avg
3.29
3Y Avg
4.75
5Y Avg
4.47
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| 20/20 Biolabs Inc. (AIDX) | $4.32M | 1.99 | 1.21 | 2.21 | 3.31 |
| CollPlant Biotechnologies Ltd. (CLGN)vs › | $4.40M | 1.57 | 3.49 | 6.45 | 7.07 |
| Processa Pharmaceuticals, Inc. (PCSA)vs › | $4.21M | 0.87 | 1.88 | 4.97 | 8.67 |
| GRI Bio, Inc. (GRI)vs › | $4.15M | 10.30 | 3.34 | 1.98 | 1.38 |
| PharmaCyte Biotech, Inc. (PMCB)vs › | $4.53M | 40.30 | 26.48 | 43.98 | 50.08 |
| Dermata Therapeutics, Inc. (DRMA)vs › | $4.55M | 2.81 | 3.29 | 4.75 | 4.47 |
| CalciMedica, Inc. (CALC)vs › | $4.69M | 5.58 | 4.46 | 3.04 | 7.15 |
| Imunon, Inc. (IMNN)vs › | $4.71M | 1.82 | 1.99 | 2.53 | 3.43 |
| Aptevo Therapeutics Inc. (APVO)vs › | $3.93M | 2.08 | 2.77 | 2.83 | 2.68 |
| Bio Green Med Solution, Inc. (BGMS)vs › | $4.72M | 8.63 | 2.65 | 2.36 | 5.21 |
Current Ratio
1.99
Quick Ratio
1.95
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 1.99 |
| 2026-03-31 | 1.82 |
| 2025-12-31 | 0.60 |
| 2025-09-30 | 0.79 |
| 2025-06-30 | 0.86 |
| 2024-12-31 | 1.50 |
| 2024-09-30 | 0.00 |
| 2023-12-31 | 4.25 |
| 2023-09-30 | 4.25 |
| 2023-06-30 | 6.00 |
| 2023-03-31 | 5.89 |
| 2022-12-31 | 5.97 |
| 2022-09-30 | 5.97 |
| 2022-06-30 | 6.00 |
| 2021-12-31 | 3.52 |
| 2021-09-30 | 3.52 |
